Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleeding

Clinical Transplantation

Volumn 18, Issue 1, 2004, Pages 85-88

  Barkan, D ^a   Nusair, S ^a   Resnick, I B ^a   Bitan, M ^a   Segel, M J ^a   Or, R ^a   Ackerstein, A ^a   Samuel, S ^a   Breuer, R ^a   Shapira, Michael Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Allogeneic stem cell transplantation; High risk patients; Pleural drainage; Pleural effusion; Tube thoracostomy

Indexed keywords

AMIKACIN; BLEOMYCIN; CARMUSTINE; CEFAZOLIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; GENTAMICIN; IFOSFAMIDE; MELPHALAN; MEZLOCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM CULTURE; CASE REPORT; DISEASE COURSE; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INFECTION RISK; MALE; NONHODGKIN LYMPHOMA; PLEURA EFFUSION; PLEURA FLUID; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; THORAX DRAINAGE; TREATMENT OUTCOME;

ADULT; BACTERIAL INFECTIONS; CHEST TUBES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGE; HUMANS; MALE; PLEURAL EFFUSION; RISK; THORACOSTOMY;

EID: 10744232876     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00123.x     Document Type: Article

References (9)

1. Slavin S, Aker M, Shapira MY et al. Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals. Transfus Apheresis Sci 2002: 27: 159.
2. Passweg JR, Socie G, Hinterberger W et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997: 90: 858.
3. Moreb J, Johnson T, Kubilis P et al.Improved survival of patients with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantation. Am J Hematol 1995: 50: 304.
4. Or R, Shapira MY, Resnick I et al. Non-myeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003: 101: 441.
5. Hayes-Jordan A, Benaim E, Richardson S et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002: 37: 446.
6. Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 2002: 78: 257.
7. Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987: 91: 817.
8. Sene MG, Corwin RW, Gold LH, Irwin RS. Complications associated with thoracocentesis. Chest 1986: 90: 97.
9. Schaap N, Raymakers R, Schattenberg A et al. Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT. Bone Marrow Transplant 1996: 18: 247.